Previous 10 | Next 10 |
Masimo Stork™ and Bowers & Wilkins Garner Six Prestigious Accolades Across Multiple Categories Masimo (NASDAQ: MASI) is proud to celebrate multiple wins across various categories at the prestigious iF DESIGN AWARDS 2024, showcasing its commitment to excellence in design a...
Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 2024 at 3:25 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . ...
Fourth Quarter 2023 Highlights: Consolidated revenue was $548.9 million; Healthcare revenue was $339.9 million; Non-healthcare revenue was $209.0 million; GAAP net income per diluted share of $0.63; and Non-GAAP net income per diluted share (updated definition) of $1.2...
First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...
2024-02-25 08:00:00 ET The last week of February promises a dynamic mix of earnings reports across various sectors. In the technology space, investors are eagerly anticipating updates from Salesforce ( NYSE: CRM ), Snowflake ( NYSE: SNOW ), Zoom Video Communications ( NASD...
2024-02-21 05:30:54 ET Summary Masimo's core segment in Professional Healthcare could have support into a multi-year growth based on current growth of Unrecognized Contract Value growth. Expansion into the consumer space is a logical extension to leverage its core tech and segment...
Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and UCHealth , a nationally recognized network of hospitals, clinics, and providers based in Colorado, announced today that they are entering into a strategic collaboration to improve the standa...
2024-02-20 08:00:00 ET Summary Masimo's favorable court ruling against Apple has boosted its shares and market share projections. In my view, the ongoing legal battle tarnishes Apple's image, while Masimo claims superiority in pulse oximetry technology. ActLight's DPD technolo...
2024-02-18 09:59:03 ET Summary Masimo Corp is set to report its full-year earnings, with expectations for a slight decline in adjusted EPS. The company's financials show manageable debt and a decent current ratio, but declining margins and profitability. The acquisition of Sou...
Masimo MightySat ® Medical Provides Clinically Proven Masimo SET ® Pulse Oximetry to Consumers for Medical Use Without a Prescription Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medic...
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Masimo Corporation ("Masimo"?or the "Company") (NA...
ATLANTA, May 14, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) complied with federal securities laws. On May 7, 2024, Masimo disclosed that it “received a subpoena ...
2024-05-12 12:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...